Changeflow GovPing Healthcare & Life Sciences Cerevance trademark TM98830357, pharmaceutical ...
Routine Notice Added

Cerevance trademark TM98830357, pharmaceutical research, neurological treatments

Email

Summary

Cerevance trademark TM98830357, pharmaceutical research, neurological treatments

Published by USPTO on changeflow.com . Detected, standardized, and enriched by GovPing. Review our methodology and editorial standards .

Archived snapshot

Apr 1, 2026

GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.

← USPTO Trademark Applications

CEREVANCE

Intent to Use TM98830357 Kind: intenttouse Mar 31, 2026

Abstract

Medical and pharmacological research services; Drug discovery services; Pharmaceutical drug development services; Scientific investigations and research for medical purposes; Research and development of vaccines and medicines; Analysis of human tissues for scientific and medical research purposes; Design and development of medical diagnostic apparatus and software applications; Providing online non-downloadable software for use in medical and pharmacological research; Software as a service (SaaS) featuring software for use in medical and pharmacological research; Providing online non-downloadable software for use in drug discovery; Software as a service (SaaS) featuring software for use in drug discovery; Providing online non-downloadable software for use in delivering drugs; Software as a service (SaaS) featuring software for use in delivering drugs; Consultancy, information and advisory services relating to all the afore-mentioned services; Downloadable software for performing medical and pharmacological research; Downloadable software applications for performing medical and pharmacological research; Downloadable software for performing drug discovery research; Downloadable software applications for performing drug discovery research; Downloadable software for use in delivering drugs; Downloadable software applications for use in delivering drugs; Pharmaceutical preparations for the treatment of central nervous system diseases and disorders; Pharmaceuticals for the treatment of obesity; Pharmaceuticals for the treatment of central nervous system diseases and disorders; Drug delivery agents in the form of injectable solutions, powders, tablets, capsules, coatings for tablets and edible wafers that provide controlled release of the active ingredients for a wide variety of pharmaceuticals

Filing Date

2024-10-31

View original document →

Get daily alerts for USPTO Trademarks - Pharmaceuticals (Class 005)

Daily digest delivered to your inbox.

Free. Unsubscribe anytime.

About this page

What is GovPing?

Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission

What's from the agency?

Source document text, dates, docket IDs, and authority are extracted directly from USPTO.

What's AI-generated?

The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.

Last updated

Classification

Agency
USPTO
Instrument
Notice

Get alerts for this source

We'll email you when USPTO Trademarks - Pharmaceuticals (Class 005) publishes new changes.

Free. Unsubscribe anytime.

You're subscribed!